ArticleFrontiers in immunology2025

Adverse drug reaction assessment of pembrolizumab in cervical cancer treatment: a real-world pharmacovigilance study using the FAERS database.

Huiping Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.